Mounjaro 7.5 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB26FWVVU
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,603
Award facts
- Contract value 100% obligated
- $3,603.25 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $3,603.25 firm fixed price delivery order on November 7, 2025, for the supply of Mounjaro 7.5 mg/0.5 mL pen (0.5 mL), a diabetes medication indicated for glycemic control. The contract is non-competitive with no set-aside designation and is scheduled for completion by November 10, 2025, with performance occurring at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at approximately $1 billion through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, has established itself as a critical federal medical procurement vendor through multiple competitively awarded contracts with the Defense Logistics Agency. The company's extensive portfolio with DLA encompasses a wide range of pharmaceutical products and medical supplies, from specialty medications and vaccines to medical devices, supporting military healthcare systems, the Defense Health Agency, and other government entities. This particular delivery order reflects the company's ongoing role as a primary supplier within DLA's pharmaceutical distribution network, ensuring continued access to essential medications for military personnel and beneficiaries.
Quick answers
Who was awarded contract SPE2DB26FWVVU?
SPE2DB26FWVVU was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 7, 2025.
How much is contract SPE2DB26FWVVU worth?
The government has obligated $3,603 on SPE2DB26FWVVU.
Is contract SPE2DB26FWVVU an order under another contract?
Yes. SPE2DB26FWVVU is a delivery order under SPE2DB25D3012, an indefinite delivery contract.
Was contract SPE2DB26FWVVU competed?
The extent of competition for SPE2DB26FWVVU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award